ABPI welcomes Labour's life sciences plan

The Labour party has today published its plan for life sciences, aimed at transforming how medical treatments are discovered and delivered. The strategy emphasises the need to encourage investment in the pharmaceutical sector.

In response, Richard Torbett, the ABPI's Chief Executive said:

“This strategy reflects the extensive and thoughtful engagement with stakeholders that the Labour party has undertaken.

"With its focus on the long term, practical measures to boost investment in research, and the emphasis on quality data to underpin future strategy, this plan will help our industry to deliver the cutting-edge treatments NHS patients need and deserve and help the UK to better compete on the global stage.”

TAGS
  • Research and Development
  • Clinical research

Last modified: 14 February 2024

Last reviewed: 14 February 2024

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.